Friday, May 16, 2025 3:38:18 PM
Recent NCNA News
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 01/06/2026 01:11:52 PM
- NuCana Appoints Theresa Bruce as Chief Operating Officer • GlobeNewswire Inc. • 01/06/2026 01:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 12/17/2025 01:12:19 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 12/10/2025 01:15:43 PM
- NuCana Presents Latest Data Demonstrating Clinical Activity and Favorable Safety for NUC-7738 in Patients with PD-1-Resistant Melanoma • GlobeNewswire Inc. • 12/10/2025 01:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 11/13/2025 09:18:32 PM
- NuCana Reports Third Quarter 2025 Financial Results and Provides Business Update • GlobeNewswire Inc. • 11/13/2025 09:01:00 PM
- NuCana Shares Climb After Securing Key Chinese Patent for Cancer Drug NUC-7738 • IH Market News • 11/05/2025 03:21:54 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 11/05/2025 01:12:19 PM
- NuCana Announces Grant of Composition-of-Matter Patent for NUC-7738 in China • GlobeNewswire Inc. • 11/05/2025 01:00:00 PM
- NuCana Presents Encouraging Data on NUC-7738 in Combination with PD-1 Inhibitors using Primary Patient-Derived Organoids and Autologous Tumor-Infiltrating Lymphocytes at the ESMO Congress 2025 • GlobeNewswire Inc. • 10/18/2025 12:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 10/14/2025 12:15:58 PM
- NuCana Announces Encouraging Data for NUC-3373 in Combination with Anti-PD-1 Therapy • GlobeNewswire Inc. • 10/14/2025 12:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 09/05/2025 12:16:52 PM
- NuCana Compliant with All Nasdaq Continued Listing Criteria • GlobeNewswire Inc. • 09/05/2025 12:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 09/03/2025 12:41:23 PM
- NuCana to Present Data on NUC-7738’s Synergy with PD-1 Inhibitors at the ESMO Congress 2025 • GlobeNewswire Inc. • 09/03/2025 12:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/20/2025 08:20:04 PM
- NuCana Reports Second Quarter 2025 Financial Results and Provides Business Update • GlobeNewswire Inc. • 08/20/2025 08:05:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/01/2025 08:22:05 PM
- NuCana Announces ADS Ratio Change • GlobeNewswire Inc. • 08/01/2025 08:05:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 07/21/2025 12:15:16 PM
- NuCana Cancels All Outstanding Series A Warrants Following Strategic ATM Execution • GlobeNewswire Inc. • 07/21/2025 12:05:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 07/11/2025 02:49:09 PM
- NuCana Announces Plan to Implement ADS Ratio Change • GlobeNewswire Inc. • 07/11/2025 02:30:39 PM
Xalles Holdings Announces Management Changes • XALL • Jan 12, 2026 8:46 AM
One World Products Enters 2026 Positioned for Disciplined Growth as Isiah Enterprises • OWPC • Jan 8, 2026 12:22 PM
ConnectM Acquires 40% of Sun Solar, Strengthening Balance Sheet and Expanding National Solar & Storage Footprint in Multi-Billion Dollar U.S. Residential Solar & Storage Market • CNTM • Jan 7, 2026 9:00 AM
EVTV Executes Transformational AZIO AI Acquisition Framework at $3.00 Per Share • EVTV • Jan 6, 2026 7:00 AM
Fifty1 Labs, Inc. Clarifies Status Regarding Previously Announced Collaboration with LUNR Aerospace • FITY • Jan 5, 2026 1:00 PM
DRCR Enters a New Phase of Growth • DRCR • Dec 31, 2025 12:04 PM
